Menu

Top Stories

Published on Thursday, April 11, 2019

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

On April 3, 2019, Francis Collins, MD, PhD, director of the National Institutes of Health (NIH), Mikael Dolsten, MD, PhD, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer, joined in a discussion led by Susan Dentzer, visiting fellow at the Robert J. Margolis Center for Health Policy, Duke University, in Washington DC.

Photo: Francis Collins, MD, PhD, director of the NIH (left) and author Alejandro Hernandez, editorial manager of the Alpha-1 Foundation (right)

For 60 minutes, Collins, Dolsten, and Dentzer engaged in a conversation with the theme of: “Advancing the innovation ecosystem: working together for patients,” where they emphasized the need for continued collaboration between the private and public sectors, along with the patient community, in order to advance new and emerging technologies and innovative approaches for potentially life-saving treatments and new outcomes in medicine.

“We are currently living in remarkable times with amazing things happening in areas such as cancer immuno-therapy, gene therapy, and gene editing. The things that are happening right now, I had no idea they would even be possible just five or six years ago,” expressed Collins when asked about the current position “the ecosystem,” as they described the collaboration between the private and public sectors with small biotech companies; an ecosystem with symbiotic characteristics where all contributors play an important role in a tremendous team effort, in medical research.

Collins and Dolsten agreed on the importance of advocacy groups and organizations as well as the patient community, in being part of the process for better outcomes and the ability to bring new and potential treatments for various conditions to the clinic, including rare diseases, such as Alpha-1 Antitrypsin Deficiency (Alpha-1). 

“We need you, the patient community, you are the reason we have gotten this far,” said Collins.

“One of the most important resources needed for this ecosystem to strive is you, the patient. We need to line-up our resources and keep the ecosystem going, including the patient community. There is no one better to bring together what others (physicians) can do than patients: you inspire all of us,” expressed Dolsten.

The Alpha-1 Foundation applauds and supports these types of initiatives, in which patients become partners and are of vital importance for therapeutic development. 

The panel also mentioned that it is critical to spread awareness and education in the medical community, and being able to have early diagnosis and detection, while mentioning the Accelerating Medicines Partnership (AMP), a public-private partnership between the NIH, the U.S. Food and Drug Administration (FDA), multiple biopharmaceutical, and life science companies, as well as non-profit organizations to transform the current model for developing new diagnostics and treatments by jointly identifying and validating promising biological targets for therapeutics.

The ultimate goal of AMP is to increase the number of new diagnostics and therapies for patients and reduce the time and cost of developing them.

“Patient participation is critical for AMP, especially to remind us what we are doing and why-and-who we are doing it for,” said Collins, who also mentioned the Foundation for the National Institutes of Health (FNIH) as being instrumental in bringing together funds and resources from both the private and public sectors, to work in mutual collaboration in research projects that will ultimately benefit the patient community.

The Alpha-1 Foundation applauds these types of initiatives that support research and bring innovative approaches to the table for the benefit of the patient community, as we are committed to finding a cure for Alpha-1 and improving the lives of Alphas, and those affected by the condition, worldwide.

For more information, please visit the Collaboration Ecosystem website and the AMP website.


Print

Alex Harrah’s Art Cars Help Him Cope with Alpha-1

Friday, March 16, 2012
Alex Harrah is a lover of art and cars, but he is particularly a fan of fixing up old cars and adding flare, turning them into works of art. You can hear it in Harrah’s voice when he talks about building his most recent “Art...
Divider

It’s all about attitude

Friday, March 16, 2012
Andrea says that keeping a positive attitude is the key to dealing with chronic illness Growing up, Andrea Maechtle was hardly ever sick. She never went to the doctor when she got a cold. She didn’t even stay home from school, or call in...
Divider

The grim diagnosis…

Friday, March 16, 2012
Alpha-1 hasn’t kept these liver kids from living full, satisfying lives In the summer of 1986, Mike and Julia Berger had their first child, Jake. Jake had yellow skin and eyes, and his bilirubin count was very high. Family and...
Divider

A One-Minute Alpha

Friday, March 16, 2012
As chairman and chief executive officer of Clear Channel Entertainment — the almost $2 billion subsidiary of media giant Clear Channel Worldwide — Brian Becker doesn’t waste a minute: actually, he has his days scheduled almost...
Divider

Brian Jackson urges family testing and awareness

Friday, March 16, 2012
Brian Jackson, 49, of Baltimore, MD, spent 20 years loving his work as a forklift operator – but he can’t do that job anymore, or play sports and was even recently told by a doctor he may someday need a lung transplant. Jackson is...
Divider

Canadian Alphas: the challenges are greater

Friday, March 16, 2012
In 2001, a small group of Canadian Alphas, carriers and caregivers decided that something needed to be done about the lack of information and support for Alphas in Canada. The most obvious difficulty facing them: a tiny Alpha-1 population in a...
Divider

Alpha-1 Caregiver steps up to lead support group

Friday, March 16, 2012
Barb Speers, the wife of a lung-affected Alpha, knows firsthand the stressful role of an Alpha-1 caregiver after her husband, Ed Speers, was diagnosed with Alpha-1 in 1997 and put on oxygen full time. When an online email list for Alpha-1...
Divider

Curtis Hamilton’s granddaughter gives him a reason to live

Friday, March 16, 2012
It was 11 o’clock on the night of Curtis Hamilton’s 57th birthday when he heard a knock on the door of his home in Richland, Mississippi. His son Curtis Jr. and daughter-in-law Wendy were there. They told him, oddly enough, they had...
Divider

The Family that Tests Together

Friday, March 16, 2012
How much do you know? How much do you want to know? Once you know more, what will you do? When a family member is diagnosed with a genetic condition like Alpha-1, these are some of the questions that arise about family testing. For Scott...
Divider

The Human Touch

Friday, March 16, 2012
Whenever Cathey Horsak feels down and discouraged, she rereads some words that she clipped from a magazine long ago. When she finds Alphas or their family members who feel the same way, she shares the clipping with them. The words come from the...
Divider

Alpha learns his lesson — and now teaches it to others

Friday, March 16, 2012
Dan Martini learned a lot from pulmonary rehab classes—so that helped him decide to become a Respiratory Therapist Dan Martini thought he knew exactly why he was short of breath: “I was overweight, lazy and smoked two packs of...
Divider

Lost and Found

Friday, March 16, 2012
In 1994, Dennis Pollock was not looking forward to attending his first Alpha-1 support group meeting – he was 34 years old, and it had been less than a year since he had been diagnosed with Alpha-1. His pulmonologist had told him that...
Divider
First60616263646566676869Last

Article Search

Enter keywords in text box and click Search button for results.

Archive